Nanoparticle formulation of ormeloxifene for pancreatic cancer

Pancreatic cancer is the fourth most prevalent cancer with about an 85% mortality rate; thus, an utmost need exists to discover new therapeutic modalities that would enhance therapy outcomes of this disease with minimal or no side effects. Ormeloxifene (ORM), a synthetic molecule, has exhibited pote...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Biomaterials
Egile Nagusiak: Khan, Sheema, Chauhan, Neeraj, Yallapu, Murali M., Ebeling, Mara C., Balakrishna, Swathi, Ellis, Robert T., Thompson, Paul A., Balabathula, Pavan, Behrman, Stephen W., Zafar, Nadeem, Singh, Man Mohan, Halaweish, Fathi T., Jaggi, Meena, Chauhan, Subhash C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4405677/
https://ncbi.nlm.nih.gov/pubmed/25890768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2015.02.082
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak